Inventor · disambiguated record
Richard Storer
Also filed as: STORER RICHARD · STORER RICHARD R SR
39 granted patents·29 pending applications·1,339 citations·filing 1978–2020
98Inventor score
Top patents by PatentIndex Score
68 records- 0199US7608600B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·181 cites·85 claims
- 0299US7365057B2Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Apr 29, 2008·118 cites·52 claims
- 0398US7635689B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 22, 2009·120 cites·29 claims
- 0498US7547704B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 16, 2009·84 cites·40 claims
- 0597US8637475B1Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infectionsSTORER RICHARD·Filed 2011·Granted Jan 28, 2014·68 cites·11 claims
- 0697US7625875B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 1, 2009·86 cites·44 claims
- 0797US7384924B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 10, 2008·77 cites·46 claims
- 0897US7192936B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsUNIV CAGLIARI·Filed 2004·Granted Mar 20, 2007·84 cites·48 claims
- 0997US6566365B1Method for the treatment of Flaviviridea viral infection using nucleoside analoguesIAF BIOCHEM INT·Filed 2000·Granted May 20, 2003·95 cites·66 claims
- 1095US8742101B2Purine nucleoside analogues for treating flaviviridae including hepatitis CSTORER RICHARD·Filed 2008·Granted Jun 3, 2014·40 cites·38 claims
- 1195US4241283AHydro-electric power plantSTORER RICHARD R SR·Filed 1978·Granted Dec 23, 1980·94 cites·8 claims
- 1293US6784161B2Method for the treatment or prevention of flavivirus infections using nucleoside analoguesIAF BIOCHEM INT·Filed 2001·Granted Aug 31, 2004·94 cites·38 claims
- 1390US7534809B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2005·Granted May 19, 2009·16 cites·82 claims
- 1487US9186369B2Purine nucleoside analogues for treating flaviviridae including hepatitis CIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·8 cites·28 claims
- 1587US7598373B2Process for the production of 2-C-methyl-D-ribonolactoneIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 6, 2009·43 cites·30 claims
- 1684US8518980B2Treatment of Duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Granted Aug 27, 2013·10 cites·4 claims
- 1783US8501713B2Drug combinations for the treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Granted Aug 6, 2013·8 cites·6 claims
- 1881US8975416B2Antibacterial compoundsDAVIS PAUL JAMES·Filed 2009·Granted Mar 10, 2015·5 cites·32 claims
- 1980US7015328B2Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereofSHIRE BIOCHEM INC·Filed 2002·Granted Mar 21, 2006·9 cites·19 claims
- 2079US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 2178US7858594B2Crystalline and amorphous forms of beta-L-2′-deoxythymidineNOVARTIS PHARMA AG·Filed 2009·Granted Dec 28, 2010·0 cites·15 claims
- 2278US6858607B17,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Feb 22, 2005·11 cites·36 claims
- 2377US9763925B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2016·Granted Sep 19, 2017·2 cites·7 claims
- 2477US9314456B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Apr 19, 2016·2 cites·3 claims
- 2576US8044091B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·2 cites·25 claims
- 2676US7589079B2Crystalline and amorphous forms of beta-L-2′-deoxythymidineNOVARTIS AG·Filed 2007·Granted Sep 15, 2009·1 cites·35 claims
- 2776US7235674B2Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Granted Jun 26, 2007·6 cites·1 claims
- 2876US2021024565A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2975US2014213540A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3074US2014113880A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3173US5155112ACyclopentane derivativesGLAXO GROUP LTD·Filed 1990·Granted Oct 13, 1992·15 cites·20 claims
- 3273US2018237467A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 3372US6609479B2Bird vaccinating device and method of operationMERIAL LTD·Filed 2002·Granted Aug 26, 2003·17 cites·22 claims
- 3472US2013330297A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3569US2010316594A1Modified 2' and 3' nucleoside prodrugs for treating flaviviridae infectionsSOMMADOSSI JEAN-PIERRE·Filed 2008·Application pending·0 cites
- 3669US2015017124A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3768US7323451B2Crystalline and amorphous forms of beta-L-2′-deoxythymidineIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Jan 29, 2008·1 cites·15 claims
- 3868US4315006ABenzoxocin derivatives having anxiolytic and anti-convulsant activitiesGLAXO GROUP LTD·Filed 1980·Granted Feb 9, 1982·6 cites·9 claims
- 3968US2017088577A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 4062US7365090B2Substituted phenylindoles for the treatment of HIVIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Apr 29, 2008·3 cites·26 claims
- 4162US6180639B11,3-oxathiolane nucleoside analoguesIAF BIOCHEM INT·Filed 1991·Granted Jan 30, 2001·25 cites·64 claims
- 4259US7476741B2Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2003·Granted Jan 13, 2009·1 cites·23 claims
- 4358US2003225037A1Method for the treatment or prevention of Flaviviridea viral infection using nucleoside analoguesIAF BIOCHEM INT·Filed 2003·Application pending·0 cites
- 4458US2004248844A1Method for the treatment or prevention of Flavivirus infections using nucleoside analoguesFiled 2004·Application pending·0 cites
- 4557US2011195929A1Compounds for the treatment of flaviviral infectionsSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 4656US2005075309A1Purine nucleoside analogues for treating Flaviviridae including hepatitis CFiled 2004·Application pending·0 cites
- 4755US2005250950A11,3-oxathiolane nucleoside analoguesCOATES JONATHAN A·Filed 2005·Application pending·0 cites
- 4853US2010048660A1Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Application pending·0 cites
- 4950US8486991B2Enantiomerically pure phosphoindoles as HIV inhibitorsSTORER RICHARD·Filed 2011·Granted Jul 16, 2013·0 cites·22 claims
- 5050US7595390B2Industrially scalable nucleoside synthesisNOVARTIS AG·Filed 2004·Granted Sep 29, 2009·0 cites·23 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →